記事一覧

• 伊賀瀬道也
  G. 脳とアンチエイジング医学（５）加齢性脳神経疾患とアンチエイジング
  「アンチエイジング医学の基礎と臨床」日本抗加齢医学会編 2015; 137-138.

• 伊賀瀬道也
  V.各論―外科治療、血管内治療の適応決定―　3.未破裂脳動脈瘤 c. 内科治療
  脳神経外科診療プラクティス5「無症候性脳血管病変を解く」飯原弘二編 2015; 243-246.

• 越智博文
  免疫性神経疾患 -基礎・臨床研究の最新知見-　多発性硬化症の治療　新規治療薬の開発状況．
  日本臨床 2015; 73(増刊7):221-227.

• 越智博文
  多発性硬化症の治療戦略．早期治療を開始するための診断とinformed consentのありかた．
  Medical Science Digest 2015; 41:548-551.

• 越智雅之，小原克彦
  心血管疾患治療におけるフレイルの重要性.
  Modern Physician 2015; 35:862-864.

• Okada Y, Kohara K, Ochi M, Nagai T, Tabara Y, Igase M, Miki T.
  Mechanical Stresses, arterial Stiffness, and Brain Small Vessel Diseases. Shimanami Health Promoting Program Study.
  Stroke. 45:3287-3292.

• Igase M, Kohara K, Tabara Y, Ohara M, Takita R, Ochi M, Okada Y, Miki T.
  Change in arterial stiffness associated with monthly bisphosphonate treatment in women with postmenopausal osteoporosis.
  Menopause. 21:962-966.

• Katsuhiko K, Ochi M, Okada Y, Yamashita T, Ohara M, Kato T, Nagai T, Tabara Y, Igase M, Miki T.
  Clinical characteristics of high plasma adiponectin and high plasma leptin as risk factors for arterial stiffness and related end-organ damage.
  Atherosclerosis. 235:424-429.

• Yamashita T, Kohara K, Tabara Y, Ochi M, Nagai T, Okada Y, Igase M, Miki T.
  Muscle Mass, Visceral Fat, and Plasma Levels of B-Type Natriuretic Peptide in Healthy Individuals(from the J-SHIPP Study).
  Am J Cardiol. 114:635-640.

• Tabara Y, Okada Y, Uetani E, Nagai T, Igase M, Kido T, Ochi N, Ohara M, Takita R, Kohara K, Miki T.
  Postprandial hypotension as a risk marker for asymptomatic lacunar infarction.
  J Hypertens. 32:1084-1090.

• Uetani E, Tabara Y, Kawamoto R, Onuma H, Kohara K, Osawa H, Miki T.
  CDH13 Gnotype-Dependent Association of High-Molecular Weight Adiponectin with All-cause Mortality:The J-SHIPP Study.
  Diabetes Care. 37:396-401.

• Kohara K
  Sarcoperic obesity in aging population: current status and future directions for research.
  Endocrine. 45:15-25.